US Stock MarketDetailed Quotes

FRTX Fresh Tracks Therapeutics

Watchlist

0.910
-0.010-1.14%

15min DelayClose Apr 26 16:00 ET

5.44MMarket Cap-858P/E (TTM)

Fresh Tracks Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

(Q1)Mar 31, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

77.54%-4.34M

56.40%-1.12M

172.55%3.08M

38.83%-1.82M

52.99%-4.49M

46.51%-19.34M

46.27%-2.58M

61.88%-4.25M

79.26%-2.97M

-61.94%-9.54M

Net income from continuing operations

73.02%-5.69M

72.65%-1.24M

134.96%2.1M

-99.13%-2.28M

54.56%-4.28M

46.54%-21.1M

25.38%-4.53M

54.59%-6.02M

89.71%-1.15M

-4.50%-9.41M

Depreciation and amortization

36.67%41K

11.11%10K

37.50%11K

66.67%10K

42.86%10K

36.36%30K

28.57%9K

14.29%8K

-14.29%6K

600.00%7K

Other non cash items

1.69%60K

--0

13.33%17K

26.67%19K

71.43%24K

-97.12%59K

-80.26%15K

--15K

--14K

Change In working capital

-39.96%-669K

-111.36%-163K

-92.80%87K

101.20%29K

11.40%-622K

16.29%-478K

143.22%1.44M

286.13%1.21M

23.35%-2.42M

-126.55%-702K

-Change in prepaid assets

-37.31%783K

-81.05%309K

-120.02%-171K

153.10%291K

151.45%354K

78.68%1.25M

3,497.92%1.63M

-53.56%854K

2.49%-548K

-29.81%-688K

-Change in payables and accrued expense

16.04%-1.39M

-165.17%-472K

-25.54%277K

86.95%-242K

-47,850.00%-955K

-31.07%-1.66M

-127.73%-178K

114.96%372K

28.53%-1.85M

-99.94%2K

-Change in other current liabilities

13.04%-60K

--0

-5.56%-19K

-17.65%-20K

-31.25%-21K

-1,280.00%-69K

-350.00%-18K

---18K

---17K

---16K

Cash from discontinued investing activities

Operating cash flow

77.54%-4.34M

56.40%-1.12M

172.55%3.08M

38.83%-1.82M

52.99%-4.49M

46.51%-19.34M

46.27%-2.58M

61.88%-4.25M

79.26%-2.97M

-61.94%-9.54M

Investing cash flow

Cash flow from continuing investing activities

-30.56%-47K

Capital expenditure reported

--0

----

-30.56%-47K

--0

----

Cash from discontinued investing activities

Investing cash flow

--0

----

-30.56%-47K

--0

----

Financing cash flow

Cash flow from continuing financing activities

454.41%6.53M

-450.00%-28K

-100.94%-10K

12,043.64%6.57M

-96.43%1.18M

-99.92%8K

-86.88%1.07M

-95.94%160K

-100.52%-55K

Net common stock issuance

449.25%6.57M

--0

--6.57M

-95.02%1.2M

--0

-86.88%1.07M

-96.67%131K

--0

Proceeds from stock option exercised by employees

--0

----

-99.59%37K

-72.41%8K

--0

----

Net other financing activities

30.91%-38K

---28K

----

-7.84%-55K

--0

---55K

Cash from discontinued financing activities

Financing cash flow

454.41%6.53M

-450.00%-28K

-100.94%-10K

--0

12,043.64%6.57M

-96.43%1.18M

-99.92%8K

-86.88%1.07M

-95.94%160K

-100.52%-55K

Net cash flow

Beginning cash position

-67.71%8.68M

6.84%12.02M

-38.20%8.95M

-37.74%10.76M

-67.71%8.68M

-10.73%26.88M

-47.39%11.25M

-40.68%14.48M

-50.29%17.29M

-10.73%26.88M

Current changes in cash

112.02%2.19M

55.18%-1.15M

195.11%3.07M

35.35%-1.82M

121.72%2.08M

-463.42%-18.2M

-146.72%-2.57M

-6.78%-3.23M

72.92%-2.81M

-305.64%-9.6M

End cash Position

25.21%10.87M

6.84%12.02M

-38.20%8.95M

-37.74%10.76M

-67.71%8.68M

-47.39%11.25M

-40.68%14.48M

-50.29%17.29M

Free cash flow

77.59%-4.34M

56.40%-1.12M

171.76%3.08M

38.83%-1.82M

52.99%-4.49M

46.43%-19.38M

46.27%-2.58M

61.46%-4.3M

79.25%-2.97M

-60.85%-9.54M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022	(Q1)Mar 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	77.54%-4.34M	56.40%-1.12M	172.55%3.08M	38.83%-1.82M	52.99%-4.49M	46.51%-19.34M	46.27%-2.58M	61.88%-4.25M	79.26%-2.97M	-61.94%-9.54M
Net income from continuing operations	73.02%-5.69M	72.65%-1.24M	134.96%2.1M	-99.13%-2.28M	54.56%-4.28M	46.54%-21.1M	25.38%-4.53M	54.59%-6.02M	89.71%-1.15M	-4.50%-9.41M
Depreciation and amortization	36.67%41K	11.11%10K	37.50%11K	66.67%10K	42.86%10K	36.36%30K	28.57%9K	14.29%8K	-14.29%6K	600.00%7K
Other non cash items	1.69%60K	--0	13.33%17K	26.67%19K	71.43%24K	-97.12%59K	-80.26%15K	--15K	--15K	--14K
Change In working capital	-39.96%-669K	-111.36%-163K	-92.80%87K	101.20%29K	11.40%-622K	16.29%-478K	143.22%1.44M	286.13%1.21M	23.35%-2.42M	-126.55%-702K
-Change in prepaid assets	-37.31%783K	-81.05%309K	-120.02%-171K	153.10%291K	151.45%354K	78.68%1.25M	3,497.92%1.63M	-53.56%854K	2.49%-548K	-29.81%-688K
-Change in payables and accrued expense	16.04%-1.39M	-165.17%-472K	-25.54%277K	86.95%-242K	-47,850.00%-955K	-31.07%-1.66M	-127.73%-178K	114.96%372K	28.53%-1.85M	-99.94%2K
-Change in other current liabilities	13.04%-60K	--0	-5.56%-19K	-17.65%-20K	-31.25%-21K	-1,280.00%-69K	-350.00%-18K	---18K	---17K	---16K
Cash from discontinued investing activities
Operating cash flow	77.54%-4.34M	56.40%-1.12M	172.55%3.08M	38.83%-1.82M	52.99%-4.49M	46.51%-19.34M	46.27%-2.58M	61.88%-4.25M	79.26%-2.97M	-61.94%-9.54M
Investing cash flow
Cash flow from continuing investing activities	0	0				-30.56%-47K	0
Capital expenditure reported	--0	--0	----	----	----	-30.56%-47K	--0	----	----	----
Cash from discontinued investing activities
Investing cash flow	--0	--0	----	----	----	-30.56%-47K	--0	----	----	----
Financing cash flow
Cash flow from continuing financing activities	454.41%6.53M	-450.00%-28K	-100.94%-10K	0	12,043.64%6.57M	-96.43%1.18M	-99.92%8K	-86.88%1.07M	-95.94%160K	-100.52%-55K
Net common stock issuance	449.25%6.57M	--0	--0	--0	--6.57M	-95.02%1.2M	--0	-86.88%1.07M	-96.67%131K	--0
Proceeds from stock option exercised by employees	--0	--0	--0	----	----	-99.59%37K	-72.41%8K	--0	----	----
Net other financing activities	30.91%-38K	---28K	----	----	----	-7.84%-55K	--0	--0	--0	---55K
Cash from discontinued financing activities
Financing cash flow	454.41%6.53M	-450.00%-28K	-100.94%-10K	--0	12,043.64%6.57M	-96.43%1.18M	-99.92%8K	-86.88%1.07M	-95.94%160K	-100.52%-55K
Net cash flow
Beginning cash position	-67.71%8.68M	6.84%12.02M	-38.20%8.95M	-37.74%10.76M	-67.71%8.68M	-10.73%26.88M	-47.39%11.25M	-40.68%14.48M	-50.29%17.29M	-10.73%26.88M
Current changes in cash	112.02%2.19M	55.18%-1.15M	195.11%3.07M	35.35%-1.82M	121.72%2.08M	-463.42%-18.2M	-146.72%-2.57M	-6.78%-3.23M	72.92%-2.81M	-305.64%-9.6M
End cash Position	25.21%10.87M	25.21%10.87M	6.84%12.02M	-38.20%8.95M	-37.74%10.76M	-67.71%8.68M	-67.71%8.68M	-47.39%11.25M	-40.68%14.48M	-50.29%17.29M
Free cash flow	77.59%-4.34M	56.40%-1.12M	171.76%3.08M	38.83%-1.82M	52.99%-4.49M	46.43%-19.38M	46.27%-2.58M	61.46%-4.3M	79.25%-2.97M	-60.85%-9.54M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall